Epo and other hematopoietic factors

Seminars in Fetal and Neonatal Medicine

Volumn 12, Issue 4, 2007, Pages 250-258

  Juul, Sandra ^a   Felderhoff Mueser, Ursula ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Development; Erythropoietin; G CSF; Growth factor; Neonatal brain injury; Neurogenesis; Neuroprotection

Indexed keywords

DEFEROXAMINE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ABSENCE OF SIDE EFFECTS; ANEMIA; BLOOD TRANSFUSION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; ERYTHROPOIESIS; HEMATOPOIESIS; HUMAN; IRON DEFICIENCY; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NEUTROPENIA; NEWBORN SEPSIS; NONHUMAN; PREMATURITY; REVIEW; TREATMENT DURATION;

ANIMALS; CENTRAL NERVOUS SYSTEM; CLINICAL TRIALS; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN, RECOMBINANT; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; GRANULOCYTE PRECURSOR CELLS; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 34249894448     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2007.01.015     Document Type: Review

References (90)

1. Nicola N.A. Cytokine pleiotropy and redundancy: a view from the receptor. Stem Cells 12 Suppl. 1 (1994) 3-12 [discussion 12-14]
2. Schneider A., Kuhn H.G., and Schabitz W.R. A role for g-csf (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 4 (2005) 1753-1757
3. Juul S. Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models. Clin Perinatol 31 (2004) 129-142
4. Konishi Y., Chui D.H., Hirose H., Kunishita T., and Tabira T. Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res 609 (1993) 29-35
5. Masuda S., Nagao M., Takahata K., Konishi Y., Gallyas Jr. F., Tabira T., et al. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 268 (1993) 11208-11216
6. Wu H., Liu X., Jaenisch R., and Lodish H.F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83 (1995) 59-67
7. Widness J.A., Schmidt R.L., and Sawyer S.T. Erythropoietin transplacental passage - review of animal studies. J Perinat Med 23 (1995) 61-70
8. Ohneda O., Yanai N., and Obinata M. Erythropoietin as a mitogen for fetal liver stromal cells which support erythropoiesis. Exp Cell Res 208 (1993) 327-331
9. 2+ mobilization and contraction in rat mesangial and aortic smooth muscle cultures. Exp Hematol 24 (1996) 392-397
10. Wu H., Lee S.H., Gao J., Liu X., and Iruela-Arispe M.L. Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development 126 (1999) 3597-3605
11. Ribatti D., Presta M., Vacca A., Ria R., Giuliani R., Dell'Era P., et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93 (1999) 2627-2636
12. Juul S.E., Joyce A.E., Zhao Y., and Ledbetter D.J. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res 46 (1999) 263-268
13. Juul S.E., Yachnis A.T., and Christensen R.D. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev 52 (1998) 235-249
14. Sawyer S.T., Krantz S.B., and Sawada K. Receptors for erythropoietin in mouse and human erythroid cells and placenta. Blood 74 (1989) 103-109
15. Mioni R., Gottardello F., Bordon P., Montini G., and Foresta C. Evidence for specific binding and stimulatory effects of recombinant human erythropoietin on isolated adult rat leydig cells. Acta Endocrinol (Copenh) 127 (1992) 459-465
16. Tabira T., Konishi Y., and Gallyas Jr. F. Neurotrophic effect of hematopoietic cytokines on cholinergic and other neurons in vitro. Int J Dev Neurosci 13 (1995) 241-252
17. Juul S.E., Yachnis A.T., Rojiani A.M., and Christensen R.D. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr Dev Pathol 2 (1999) 148-158
18. Iguchi T., Sogo S., Hisha H., Taketani S., Adachi Y., Miyazaki R., et al. Hgf activates signal transduction from epo receptor on human cord blood cd34+/cd45+ cells. Stem Cells 17 (1999) 82-91
19. Akahane K., Tojo A., Urabe A., and Takaku F. Pure erythropoietic colony and burst formations in serum-free culture and their enhancement by insulin-like growth factor 1. Exp Hematol 15 (1987) 797-802
20. Buescher U., Hertwig K., Wolf C., and Dudenhausen J.W. Erythropoietin in amniotic fluid as a marker of chronic fetal hypoxia. Int J Gynaecol Obstet 60 (1998) 257-263
21. Stangenberg M., Legarth J., Cao H.L., Lingman G., Persson B., Rahman F., et al. Erythropoietin concentrations in amniotic fluid and umbilical venous blood from Rh-immunized pregnancies. J Perinat Med 21 (1993) 225-234
22. Ohls R.K., Harcum J., Li Y., Davila G., and Christensen R.D. Serum erythropoietin concentrations fail to increase after significant phlebotomy losses in ill preterm infants. J Perinatol 17 (1997) 465-467
23. Rhondeau S.M., Christensen R.D., Ross M.P., Rothstein G., and Simmons M.A. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "Anemia of prematurity". J Pediatr 112 (1988) 935-940
24. Ohlsson A., and Aher S.M. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 3 (2006) [CD004863]
25. Aher S., and Ohlsson A. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 3 (2006) [CD004868]
26. Garcia M.G., Hutson A.D., and Christensen R.D. Effect of recombinant erythropoietin on "Late" Transfusions in the neonatal intensive care unit: a meta-analysis. J Perinatol 22 (2002) 108-111
27. Pollak A., Hayde M., Hayn M., Herkner K., Lombard K.A., Lubec G., et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pediatrics 107 (2001) 78-85
28. Haiden N., Klebermass K., Cardona F., Schwindt J., Berger A., Kohlhauser-Vollmuth C., et al. A randomized, controlled trial of the effects of adding vitamin b12 and folate to erythropoietin for the treatment of anemia of prematurity. Pediatrics 118 (2006) 180-188
29. Ohls R.K., and Dai A. Long-acting erythropoietin: clinical studies and potential uses in neonates. Clin Perinatol 31 (2004) 77-89
30. Masuda S., Okano M., Yamagishi K., Nagao M., Ueda M., and Sasaki R. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269 (1994) 19488-19493
31. Brines M., and Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6 (2005) 484-494
32. Coleman T., and Brines M. Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?. Crit Care 8 (2004) 337-341
33. Ozer E.A., Kumral A., Ozer E., Yilmaz O., Duman N., Ozkal S., et al. Effects of erythropoietin on hyperoxic lung injury in neonatal rats. Pediatr Res 58 (2005) 38-41
34. Juul S.E., McPherson R.J., Farrell F.X., Jolliffe L., Ness D.J., and Gleason C.A. Erytropoietin concentrations in cerebrospinal fluid of non-human primates and fetal sheep following high-dose recombinant erythropoietin. Biol Neonate 85 (2004) 138-144
35. Bernaudin M., Marti H.H., Roussel S., Divoux D., Nouvelot A., MacKenzie E.T., et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19 (1999) 643-651
36. Siren A.L., Knerlich F., Poser W., Gleiter C.H., Bruck W., and Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (Berl) 101 (2001) 271-276
37. Juul S.E., Stallings S.A., and Christensen R.D. Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury. Pediatr Res 46 (1999) 543-547
38. Juul S.E., Anderson D.K., Li Y., and Christensen R.D. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 43 (1998) 40-49
39. Leist M., Ghezzi P., Grasso G., Bianchi R., Villa P., Fratelli M., et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305 (2004) 239-242
40. Wang X., Zhu C., Wang X., Gerwien J.G., Schrattenholz A., Sandberg M., et al. The non-erythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. J Neurochem 91 (2004) 900-910
41. Yu X., Lin C.S., Costantini F., and Noguchi C.T. The human erythropoietin receptor gene rescues erythropoiesis and developmental defects in the erythropoietin receptor null mouse. Blood 98 (2001) 475-477
42. Digicaylioglu M., and Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between jak2 and nf-kappaB signalling cascades. Nature 412 (2001) 641-647
43. Chong Z.Z., Kang J.Q., and Maiese K. Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 22 (2002) 503-514
44. Sola A., Rogido M., Lee B.H., Genetta T., and Wen T.C. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatr Res 57 (2005) 481-487
45. Matsushita H., Johnston M.V., Lange M.S., and Wilson M.A. Protective effect of erythropoietin in neonatal hypoxic ischemia in mice. Neuroreport 14 (2003) 1757-1761
46. Kumral A., Genc S., Ozer E., Yilmaz O., Gokmen N., Koroglu T.F., et al. Erythropoietin downregulates bax and dp5 proapoptotic gene expression in neonatal hypoxic-ischemic brain injury. Biol Neonate 89 (2006) 205-210
47. Sun Y., Zhou C., Polk P., Nanda A., and Zhang J.H. Mechanisms of erythropoietin-induced brain protection in neonatal hypoxia-ischemia rat model. J Cereb Blood Flow Metab 24 (2004) 259-270
48. Spandou E., Soubasi V., Papoutsopoulou S., Karkavelas G., Simeonidou C., Kaiki-Astara A., et al. Erythropoietin prevents hypoxia/ischemia-induced DNA fragmentation in an experimental model of perinatal asphyxia. Neurosci Lett 366 (2004) 24-28
49. Sun Y., Calvert J.W., and Zhang J.H. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 36 (2005) 1672-1678
50. Keller M., Yang J., Griesmaier E., Gorna A., Sarkozy G., Urbanek M., et al. Erythropoietin is neuroprotective against nmda-receptor-mediated excitotoxic brain injury in newborn mice. Neurobiol Dis 24 (2006) 357-366
51. Kawakami M., Iwasaki S., Sato K., and Takahashi M. Erythropoietin inhibits calcium-induced neurotransmitter release from clonal neuronal cells. Biochem Biophys Res Commun 279 (2000) 293-297
52. Tsai P.T., Ohab J.J., Kertesz N., Groszer M., Matter C., Gao J., et al. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci 26 (2006) 1269-1274
53. Wang L., Zhang Z., Wang Y., Zhang R., and Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35 (2004) 1732-1737
54. Chang Y.S., Mu D., Wendland M., Sheldon R.A., Vexler Z.S., McQuillen P.S., et al. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res 58 (2005) 106-111
55. Demers E.J., McPherson R.J., and Juul S.E. Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res 58 (2005) 297-301
56. Wei L., Han B.H., Li Y., Keogh C.L., Holtzman D.M., and Yu S.P. Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J Pharmacol Exp Ther 317 (2006) 109-116
57. Um M., and Lodish H.F. Antiapoptotic effects of erythropoietin in differentiated neuroblastoma sh-sy5y cells require activation of both the stat5 and akt signaling pathways. J Biol Chem 281 (2006) 5648-5656
58. Dzietko M., Felderhoff-Mueser U., Sifringer M., Krutz B., Bittigau P., Thor F., et al. Erythropoietin protects the developing brain against N-methyl-d-aspartate receptor antagonist neurotoxicity. Neurobiol Dis 15 (2004) 177-187
59. Solaroglu I., Solaroglu A., Kaptanoglu E., Dede S., Haberal A., Beskonakli E., et al. Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain. Childs Nerv Syst 19 (2003) 19-22
60. Kumral A., Baskin H., Gokmen N., Yilmaz O., Genc K., Genc S., et al. Selective inhibition of nitric oxide in hypoxic-ischemic brain model in newborn rats: Is it an explanation for the protective role of erythropoietin?. Biol Neonate 85 (2004) 51-54
61. Villa P., Bigini P., Mennini T., Agnello D., Laragione T., Cagnotto A., et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198 (2003) 971-975
62. Mu D., Chang Y.S., Vexler Z.S., and Ferriero D.M. Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. Exp Neurol 195 (2005) 407-415
63. Ohls R.K., Ehrenkranz R.A., Das A., Dusick A.M., Yolton K., Romano E., et al. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 114 (2004) 1287-1291
64. Bierer R., Peceny M.C., Hartenberger C.H., and Ohls R.K. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 118 (2006) e635-e640
65. Higgins R.D., Raju T.N., Perlman J., Azzopardi D.V., Blackmon L.R., Clark R.H., et al. Hypothermia and perinatal asphyxia: executive summary of the national institute of child health and human development workshop. J Pediatr 148 (2006) 170-175
66. Dallman P.R. Biochemical basis for the manifestations of iron deficiency. Annu Rev Nutr 6 (1986) 13-40
67. Lozoff B., Jimenez E., Hagen J., Mollen E., and Wolf A.W. Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics 105 (2000) E51
68. Buonocore G., Perrone S., and Bracci R. Free radicals and brain damage in the newborn. Biol Neonate 79 (2001) 180-186
69. Demetri G.D., and Griffin J.D. Granulocyte colony-stimulating factor and its receptor. Blood 78 (1991) 2791-2808
70. Drossou-Agakidou V., Kanakoudi-Tsakalidou F., Sarafidis K., Taparkou A., Tzimouli V., Tsandali H., et al. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial. Eur J Pediatr 157 (1998) 583-588
71. Bensinger W., Appelbaum F., Rowley S., Storb R., Sanders J., Lilleby K., et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13 (1995) 2547-2555
72. Carlsson G., Ahlin A., Dahllof G., Elinder G., Henter J.I., and Palmblad J. Efficacy and safety of two different rg-csf preparations in the treatment of patients with severe congenital neutropenia. Br J Haematol 126 (2004) 127-132
73. Miura E., Procianoy R.S., Bittar C., Miura C.S., Miura M.S., Mello C., et al. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Pediatrics 107 (2001) 30-35
74. Carr R., Modi N., and Dore C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev (2003) [CD003066]
75. Carr R., and Modi N. Haemopoietic growth factors for neonates: assessing risks and benefits. Acta Paediatr Suppl 93 (2004) 15-19
76. Schabitz W.R., Kollmar R., Schwaninger M., Juettler E., Bardutzky J., Scholzke M.N., et al. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34 (2003) 745-751
77. Lee S.T., Chu K., Jung K.H., Ko S.Y., Kim E.H., Sinn D.I., et al. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res 1058 (2005) 120-128
78. Solaroglu I., Cahill J., Jadhav V., and Zhang J.H. A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 37 (2006) 1123-1128
79. Gibson C.L., Jones N.C., Prior M.J., Bath P.M., and Murphy S.P. G-csf suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice. J Neuropathol Exp Neurol 64 (2005) 763-769
80. Komine-Kobayashi M., Zhang N., Liu M., Tanaka R., Hara H., Osaka A., et al. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 26 (2006) 402-413
81. Keller M., Simbruner G., Gorna A., Urbanek M., Tinhofer I., Griesmaier E., et al. Systemic application of granulocyte-colony stimulating factor and stem cell factor exacerbates excitotoxic brain injury in newborn mice. Pediatr Res 59 (2006) 549-553
82. Weber A., Dzietko M., Berns M., Felderhoff-Mueser U., Heinemann U., Maier R.F., et al. Neuronal damage after moderate hypoxia and erythropoietin. Neurobiol Dis 20 (2005) 594-600
83. McPherson R.J., Demers E.J., and Juul S.E. Safety of high-dose recombinant erythropoietin in a neonatal rat model. Neonatology 91 (2007) 36-43
84. McClure M.M., Threlkeld S.W., and Fitch R.H. The effects of erythropoietin on auditory processing following neonatal hypoxic-ischemic injury. Brain Res 1087 (2006) 190-195
85. Spandou E., Papadopoulou Z., Soubasi V., Karkavelas G., Simeonidou C., Pazaiti A., et al. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res 1045 (2005) 22-30
86. Wang C.H., Liang C.L., Huang L.T., Liu J.K., Hung P.H., Sun A., et al. Single intravenous injection of naked plasmid DNA encoding erythropoietin provides neuroprotection in hypoxia-ischemia rats. Biochem Biophys Res Commun 314 (2004) 1064-1071
87. Kumral A., Gonenc S., Acikgoz O., Sonmez A., Genc K., Yilmaz O., et al. Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 87 (2005) 15-18
88. Kumral A., Uysal N., Tugyan K., Sonmez A., Yilmaz O., Gokmen N., et al. Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav Brain Res 153 (2004) 77-86
89. Kumral A., Ozer E., Yilmaz O., Akhisaroglu M., Gokmen N., Duman N., et al. Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 83 (2003) 224-228
90. Aydin A., Genc K., Akhisaroglu M., Yorukoglu K., Gokmen N., and Gonullu E. Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic-ischemic brain injury. Brain Dev 25 (2003) 494-498